← Leaderboards
Katelyn Melgar
Cincinnati Childrens Hosp Med Ctr
$111,624
Attributed
$111,624
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.7K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$111,624 · 1
By mechanism
F31$111,624 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Daniel Starczynowski$17,551,895
- H Leighton Grimes$23,205,568
- Daniel Lucas$9,614,171
- Mohammad Azam$5,839,846
- Gang Huang$4,401,757
Others in their field
Other Emerging Leaders on “Acute Myelocytic Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Leonard Freedman · Leidos Biomedical Research, Inc.$12,430,568
- Crystal Mackall · Children'S Hosp Of Philadelphia$6,450,142
- Christopher A Miller · Washington University$5,424,298
- Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,329,699
- Kelly Diringer Getz · University Of Pennsylvania$4,068,250
Research focus
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaAnimal ModelApoptosisBaseBinding SitesCancer CellCellsCell SurvivalChemotherapyClinical TrialsCombatComplexDisease RegressionDisease RemissionDisease ResistanceDoseDrug CombinationsDrug DiscoveryDrug InteractionsDrug ResistanceDysmyelopoietic SyndromesEffective TherapyEvolution
Grant awards (4)
Novel mechanisms and therapeutic strategies of refractory leukemia$34,230
F31 · FY2019 · CA · contact PI
Novel mechanisms and therapeutic strategies of refractory leukemia$3,466
F31 · FY2019 · CA · contact PI
Novel mechanisms and therapeutic strategies of refractory leukemia$37,204
F31 · FY2018 · CA · contact PI
Novel mechanisms and therapeutic strategies of refractory leukemia$36,724
F31 · FY2017 · CA · contact PI